BioNTech • BNTX
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid.
Ratings
2.5 / 5
2 ratings in the last 12 months
5
4
3
2
1
CEO
Professor Ugur Sahin, M.D.$20.4B
Market Cap • 25/07/20242008
(há 16 anos)
2019
(5 years ago)
NASDAQ
Listagem
Mainz
Sede • RP4.530
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
BNTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.